Initial recommended short opened at $48 is 26% in profit, with leverage huge success.
ICP still following descending channel, volume is extremely bearish. Looking at a second test of $30, if broken;
TP @ $28.
If liquidation is above $58, recommend against closing the position until $9 (taking a 2X multiple of fake quoted VC price of $4.50, believe we could see a renewed scalper attention at this level).
With the CEO of Dfinity, Dominic Williams stating a proposal of Kusama esque move for ICP that has gotten an extremely negative response, and Dfinity/VC’s controlling ICP’s governance making the proposal more of a stated direction, this move would have a large negative effect on price.
If the BDL token is launched, I’d recommend immediately shorting it.
Also, believe Huobi and OKEX are offering the capability of shorting ICP. FTX has for awhile.
Please no Dfinity/ICP shills, just a followup on a successful trading recommendation.
ICP still following descending channel, volume is extremely bearish. Looking at a second test of $30, if broken;
TP @ $28.
If liquidation is above $58, recommend against closing the position until $9 (taking a 2X multiple of fake quoted VC price of $4.50, believe we could see a renewed scalper attention at this level).
With the CEO of Dfinity, Dominic Williams stating a proposal of Kusama esque move for ICP that has gotten an extremely negative response, and Dfinity/VC’s controlling ICP’s governance making the proposal more of a stated direction, this move would have a large negative effect on price.
If the BDL token is launched, I’d recommend immediately shorting it.
Also, believe Huobi and OKEX are offering the capability of shorting ICP. FTX has for awhile.
Please no Dfinity/ICP shills, just a followup on a successful trading recommendation.
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.